BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20617388)

  • 21. [Influence of European regulations on quality, safety and availability of cell and tissue allografts in Germany].
    Pruss A; von Versen R
    Handchir Mikrochir Plast Chir; 2007 Apr; 39(2):81-7. PubMed ID: 17497601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coding and traceability for cells, tissues and organs for transplantation.
    Strong DM; Shinozaki N
    Cell Tissue Bank; 2010 Nov; 11(4):305-23. PubMed ID: 20464502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstacles to European research projects with data and tissue: solutions and further challenges.
    van Veen EB
    Eur J Cancer; 2008 Jul; 44(10):1438-50. PubMed ID: 18440221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report on the RCDS-CDHSRU workshop on developing clinical guidelines/standards of practice.
    Leake JL; Main PA; Woodward GL
    J Can Dent Assoc; 1996 Jul; 62(7):570-7. PubMed ID: 8764676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of ISBT 128, a quality system, a standardized bar code labeling of blood products worldwide, electronic transfusion pathway: four years of experience in Norway.
    Aandahl GS; Knutsen TR; Nafstad K
    Transfusion; 2007 Sep; 47(9):1674-8. PubMed ID: 17725733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Logistics and European laws on allogeneic tissue transplantation].
    Verdonk R; Almquist KF; Verdonk P
    Orthopade; 2008 Aug; 37(8):779-82. PubMed ID: 18542918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for education and training of medical physicists in radiotherapy. Recommendations from an ESTRO/EFOMP working group.
    Eudaldo T; Huizenga H; Lamm IL; McKenzie A; Milano F; Schlegel W; Thwaites D; Heeren G; ;
    Radiother Oncol; 2004 Feb; 70(2):125-35. PubMed ID: 15028400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Models for representation of terminologies and coding systems in medicine.
    Mori AR; Bernauer J; Pakarinen V; Rector AL; De Vries-Robbé P; Ceusters W; Hurlen P; Ogonowski A; Olesen H
    Stud Health Technol Inform; 1993; 6():92-104. PubMed ID: 10184636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of tissue discards after implementation of anti-HBc test in a tissue bank in Spain.
    Villalba R; Fornés G; Eisman M; Gómez Villagrán JL
    Cell Tissue Bank; 2007; 8(4):303-5. PubMed ID: 17447156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biorepository standards and protocols for collecting, processing, and storing human tissues.
    Troyer D
    Methods Mol Biol; 2008; 441():193-220. PubMed ID: 18370320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing risks--challenges posed by the European general product safety directive.
    van Aken D
    Inj Control Saf Promot; 2002 Sep; 9(3):151-6. PubMed ID: 12462167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European quality system for tissue banking.
    Manyalich M; Navarro A; Koller J; Loty B; de Guerra A; Cornu O; Vabels G; Fornasari PM; Costa AN; Siska I; Hirn M; Franz N; Miranda B; Kaminski A; Uhrynowska I; Van Baare J; Trias E; Fernández C; de By T; Poniatowski S; Carbonell R
    Transplant Proc; 2009; 41(6):2035-43. PubMed ID: 19715826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ISBT 128 coding and labeling for cellular therapy products.
    Slaper-Cortenbach I
    Cell Tissue Bank; 2010 Nov; 11(4):375-8. PubMed ID: 20857223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Community requirements relating to drugs derived from human blood and plasma].
    Brunko P
    Ann Pharm Fr; 1994; 52(2):89-98. PubMed ID: 7944184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [To what extent is organ procurement acceptable? The legal framework and European legislation].
    Van Haelewijck B
    Rev Med Brux; 1999 Sep; 20(4):A283-6. PubMed ID: 10523906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of an ISBT 128-Compatible Medical Record System to Facilitate Traceability of Stem Cell Products.
    Boğa C; Maytalman E; Gereklioğlu Ç; Asma S; Kandemir F; Aytan P; Korur A; Yeral M; Kozanoğlu İ; Özdoğu H
    Turk J Haematol; 2017 Aug; 34(3):280-281. PubMed ID: 28443818
    [No Abstract]   [Full Text] [Related]  

  • 38. Recommendations of the ECVAM Workshop on "Alternatives to Animal Testing in the Quality Control of Immunobiologicals; State of the Art and Future Prospects".
    Hendriksen CF
    ALTEX; 1994; 11(5):19-20. PubMed ID: 11178401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical examination of the potential tissue donor, what do European tissue banks do?
    Van Geyt C; Van Wijk M; Bokhorst A; Beele H
    Clin Transplant; 2010; 24(2):259-64. PubMed ID: 19758270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.